Sex Hormone-Binding Globulin as More Than a Biomarker of Metabolic Diseases and Reproductive Disorders: What Physicians Should Know?

    Alessandra Covallero Renck, Ericka Barbosa Trarbach, Sérgio Brasil, Elaine Maria Frade Costa
    Studysummary This review consolidates existing research showing that lower SHBG levels are significantly associated with adverse reproductive, metabolic, and cardiovascular outcomes, suggesting its importance as a marker in managing various health conditions.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →